Insider Transactions in Q4 2020 at Intercept Pharmaceuticals, Inc. (ICPT)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2020
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
SELL
Payment of exercise price or tax liability
|
Direct |
706
-3.32%
|
$16,944
$24.7 P/Share
|
Dec 31
2020
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,700
-4.38%
|
$40,800
$24.7 P/Share
|
Dec 31
2020
|
Jason Campagna Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
534
-6.21%
|
$12,816
$24.7 P/Share
|
Dec 31
2020
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
629
-4.72%
|
$15,096
$24.7 P/Share
|
Dec 31
2020
|
Sandip Kapadia CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
859
-3.16%
|
$20,616
$24.7 P/Share
|
Dec 31
2020
|
Richard J Kim President US Comm & Strat Mktg |
SELL
Payment of exercise price or tax liability
|
Direct |
799
-3.84%
|
$19,176
$24.7 P/Share
|
Dec 31
2020
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
25,065
-4.85%
|
$601,560
$24.7 P/Share
|
Dec 31
2020
|
Mark Pruzanski Director |
BUY
Grant, award, or other acquisition
|
Direct |
41,236
+7.39%
|
$989,664
$24.7 P/Share
|
Dec 31
2020
|
Christian Weyer EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-4.88%
|
$18,696
$24.7 P/Share
|
Dec 15
2020
|
Sandip Kapadia CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,763
-6.1%
|
$56,416
$32.78 P/Share
|
Nov 27
2020
|
Christian Weyer EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
357
-2.19%
|
$13,209
$37.27 P/Share
|
Nov 23
2020
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-0.82%
|
$11,165
$35.47 P/Share
|
Nov 13
2020
|
Ryan T Sullivan General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
493
-1.96%
|
$18,241
$37.87 P/Share
|
Nov 12
2020
|
Gail Cawkwell SVP, Med Affairs, Safety & PV |
SELL
Payment of exercise price or tax liability
|
Direct |
319
-1.48%
|
$12,122
$38.52 P/Share
|
Nov 08
2020
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
128
-0.95%
|
$3,584
$28.15 P/Share
|
Oct 01
2020
|
David A Ford Chief Human Resources Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.68%
|
$3,864
$42.08 P/Share
|
Oct 01
2020
|
Sandip Kapadia CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
296
-1.01%
|
$12,432
$42.08 P/Share
|
Oct 01
2020
|
Richard J Kim President US Comm & Strat Mktg |
SELL
Payment of exercise price or tax liability
|
Direct |
223
-1.06%
|
$9,366
$42.08 P/Share
|
Oct 01
2020
|
Mark Pruzanski Director |
SELL
Payment of exercise price or tax liability
|
Direct |
772
-0.16%
|
$32,424
$42.08 P/Share
|
Oct 01
2020
|
Christian Weyer EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-0.28%
|
$1,932
$42.08 P/Share
|
Oct 01
2020
|
Jerome Benedict Durso CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
289
-0.73%
|
$12,138
$42.08 P/Share
|
Oct 01
2020
|
Jason Campagna Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
112
-1.29%
|
$4,704
$42.08 P/Share
|